Pacific Channel highlights syndication benefits in deep-tech bets such as SWAN Genomics

• Pacific Channel highlighted syndication as a core investment approach to strengthen diligence, capital access, and post-investment support across deep-tech.
• Baymatob cited as an early case where investors jointly evaluated the opportunity before committing capital, later expanding into broader deal-sharing.
• SWAN Genomics referenced as a syndicated investment that drew on shared technical analysis with lead investor Proto Axiom, later used to bring in more investors.
• Wellumio described as a portfolio example where co-investor collaboration supported conviction, with relationships later extending across multiple portfolio companies.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pacific Channel Ltd published the original content used to generate this news brief on July 24, 2026, and is solely responsible for the information contained therein.